Vaccine efficacy against persistent human papillomavirus (HPV) 16/18 infection at 10 years after one, two, and three doses of quadrivalent HPV vaccine in girls in India: a multicentre, prospective, cohort study

BACKGROUND: A randomised trial designed to compare three and two doses of quadrivalent human papillomavirus (HPV) vaccine in adolescent girls in India was converted to a cohort study after suspension of HPV vaccination in trials by the Indian Government. In this Article, the revised aim of the cohor...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Partha, Malvi, Sylla G, Joshi, Smita, Bhatla, Neerja, Muwonge, Richard, Lucas, Eric, Verma, Yogesh, Esmy, Pulikkottil O, Poli, Usha Rani Reddy, Shah, Anand, Zomawia, Eric, Pimple, Sharmila, Jayant, Kasturi, Hingmire, Sanjay, Chiwate, Aruna, Divate, Uma, Vashist, Shachi, Mishra, Gauravi, Jadhav, Radhika, Siddiqi, Maqsood, Sankaran, Subha, Prabhu, Priya Ramesh, Kannan, Thiraviam Pillai Rameshwari Ammal, Varghese, Rintu, Shastri, Surendra S, Anantharaman, Devasena, Gheit, Tarik, Tommasino, Massimo, Sauvaget, Catherine, Pillai, M Radhakrishna, Sankaranarayanan, Rengaswamy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8560643/
https://www.ncbi.nlm.nih.gov/pubmed/34634254
http://dx.doi.org/10.1016/S1470-2045(21)00453-8

Ejemplares similares

Ejemplares similares